Loss of endothelin type B receptor function improves insulin sensitivity in rats.
Loss of endothelin type B receptor function improves insulin sensitivity in rats.
复制标题
DOI:
10.1139/cjpp-2019-0666
复制
发表时间:
2020-02
影响因子:
2.1
通讯作者:
Osvaldo Rivera-Gonzalez;M. Kasztan;Jermaine G. Johnston;Kelly A. Hyndman;Joshua S. Speed
中科院分区:
文献类型:
--
作者:
Osvaldo Rivera-Gonzalez;M. Kasztan;Jermaine G. Johnston;Kelly A. Hyndman;Joshua S. Speed
High salt intake (HS) is associated with obesity and insulin resistance. ET-1, a peptide released in response to HS, inhibits the actions of insulin on cultured adipocytes through ET-1 type B (ETB) receptors; however, the in vivo implications of ETB receptor activation on lipid metabolism and insulin resistance is unknown. We hypothesized that activation of ETB receptors in response to HS intake promotes dyslipidemia and insulin resistance. In normal salt (NS) fed rats, no significant difference in body weight or epidydimal fat mass was observed between control and ETB deficient rats. After 2 weeks of HS, ETB def rats had significantly lower body weight and epidydimal fat mass compared to controls. Non-fasting plasma glucose was not different between genotypes, however plasma insulin concentration was significantly lower in ETB deficient rats compared to controls suggesting improved insulin sensitivity. In addition, ETB deficient rats had higher circulating free fatty acids in both NS and HS groups, with no difference in plasma triglycerides between genotypes. In a separate experiment, ETB deficient rats had significantly lower fasting blood glucose and improved glucose and insulin tolerance compared to controls. These data suggest that ET-1 promotes adipose deposition and insulin resistance via the ETB receptor.